Organization
Armaceutica
1 clinical trial
Clinical trial
A Phase 2a, Multi-centre, Randomised, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of Pyronaridine as an Add-on Therapy in Adults With Acute Lymphoblastic Leukemia and Acute Myeloid LeukemiaStatus: Recruiting, Estimated PCD: 2024-02-01